HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3

Cisplatin is the most frequently used agent for chemotherapy against cervical cancer. However, recurrent use of cisplatin induces resistance, representing a major hurdle in the treatment of cervical cancer. Our previous study revealed that HP1γ suppresses UBE2L3, an E2 ubiquitin conjugating enzyme,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Sang Ah, Kim, Go Woon, Yoo, Jung, Han, Jeung-Whan, Kwon, So Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503686/
https://www.ncbi.nlm.nih.gov/pubmed/32825184
http://dx.doi.org/10.3390/ijms21175976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503686/
https://www.ncbi.nlm.nih.gov/pubmed/32825184
http://dx.doi.org/10.3390/ijms21175976

Ejemplares similares